Tsutomu Nishimura

Summary

Affiliation: Kyoto University
Country: Japan

Publications

  1. doi request reprint A 1-μT extremely low-frequency electromagnetic field vs. sham control for mild-to-moderate hypertension: a double-blind, randomized study
    Tsutomu Nishimura
    Department of Clinical Trial Design and Management, Translational Research Center, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Hypertens Res 34:372-7. 2011
  2. doi request reprint Lizards respond to an extremely low-frequency electromagnetic field
    Tsutomu Nishimura
    Translational Research Center, Graduate School of Medicine, Kyoto University, Shogoin kawahara cho 54, Sakyo ku, Kyoto, 606 8507, Japan
    J Exp Biol 213:1985-90. 2010
  3. pmc The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgery
    Takayoshi Kiba
    Outpatient Oncology Unit, Kyoto University Hospital, Kyoto, Japan
    BMC Cancer 8:323. 2008
  4. pmc Interstitial lung disease in gefitinib-treated Japanese patients with non-small cell lung cancer - a retrospective analysis: JMTO LC03-02
    Masatsugu Nakagawa
    Department of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, Kyoto, Japan
    BMC Res Notes 2:157. 2009
  5. ncbi request reprint Prevalence and incidence of anemia in Japanese cancer patients receiving outpatient chemotherapy
    Toshiyuki Kitano
    Department of Translational Clinical Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Int J Hematol 86:37-41. 2007

Collaborators

Detail Information

Publications5

  1. doi request reprint A 1-μT extremely low-frequency electromagnetic field vs. sham control for mild-to-moderate hypertension: a double-blind, randomized study
    Tsutomu Nishimura
    Department of Clinical Trial Design and Management, Translational Research Center, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Hypertens Res 34:372-7. 2011
    ..There were no adverse events other than mild paresthesia of the hands of two subjects in the ELF-EMF group. Our results suggest that repeated exposure to an ELF-EMF has a BP-lowering effect on humans with mild-to-moderate hypertension...
  2. doi request reprint Lizards respond to an extremely low-frequency electromagnetic field
    Tsutomu Nishimura
    Translational Research Center, Graduate School of Medicine, Kyoto University, Shogoin kawahara cho 54, Sakyo ku, Kyoto, 606 8507, Japan
    J Exp Biol 213:1985-90. 2010
    ..Our experiments suggest that (1) lizards perceive EMFs and (2) the parietal eye may be involved in light-dependent magnetoreceptive responses...
  3. pmc The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgery
    Takayoshi Kiba
    Outpatient Oncology Unit, Kyoto University Hospital, Kyoto, Japan
    BMC Cancer 8:323. 2008
    ..Previous studies have shown that patients with estrogen receptor (ER) positive cancers have a better prognosis than patients whose cancers do not have these receptors...
  4. pmc Interstitial lung disease in gefitinib-treated Japanese patients with non-small cell lung cancer - a retrospective analysis: JMTO LC03-02
    Masatsugu Nakagawa
    Department of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, Kyoto, Japan
    BMC Res Notes 2:157. 2009
    ..Future studies should be aimed at identifying factors indicating that a patient has a high probability of receiving benefit from gefitinib and a low risk of developing ILD...
  5. ncbi request reprint Prevalence and incidence of anemia in Japanese cancer patients receiving outpatient chemotherapy
    Toshiyuki Kitano
    Department of Translational Clinical Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Int J Hematol 86:37-41. 2007
    ..Better recognition and management of cancer-related anemia are required in Japan. To this end, randomized controlled trials evaluating the effects of erythropoietic agents on patients' survival and quality of life are necessary...